|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.50 GBX | 0.00% |
|
-0.91% | +0.93% |
| 07-08 | Gym Group revenue rises; Central Asia output up | AN |
| 07-08 | Itaconix plc and Bonals Technologies Extend Agreement | CI |
| Market Cap | 14.63M 19.6M 17.17M 15.85M 27.75M 1.87B 28.2M 189M 74.24M 921M 73.55M 72M 3.17B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 12.18M 16.32M 14.3M 13.2M 23.11M 1.56B 23.48M 158M 61.82M 767M 61.24M 59.95M 2.64B | EV / Sales 2026 * |
1.23x | EV / Sales 2027 * | 1.09x |
| Free-Float |
84.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Itaconix plc
| 1 week | -0.91% | ||
| Current month | -2.25% | ||
| 1 month | -5.24% | ||
| 3 months | +3.33% | ||
| 6 months | +0.93% | ||
| Current year | +0.93% |
| 1 week | 107 | 114 | |
| 1 month | 107 | 115 | |
| Current year | 97 | 125 | |
| 1 year | 97 | 142 | |
| 3 years | 92.5 | 274 | |
| 5 years | 92.5 | 615 | |
| 10 years | 13 | 2,000 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yvon Durant
CTO | Chief Tech/Sci/R&D Officer | - | - |
John Shaw
CEO | Chief Executive Officer | 66 | 11/07/2018 |
Laura Denner
DFI | Director of Finance/CFO | 43 | 31/10/2013 |
| Director | Title | Age | Since |
|---|---|---|---|
John Shaw
BRD | Director/Board Member | 66 | 11/07/2018 |
Laura Denner
BRD | Director/Board Member | 43 | 19/07/2022 |
| Chairman | 55 | 04/07/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-04 | Buy | Chairman | 3,400 | 0.0252% | ||
| 04-22 | Free | Chief Financial Officer | 80,916 | 0.6000% | ||
| 04-22 | Free | Founder | 14,871 | 0.1103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | -0.91% | -14.23% | -45.75% | 19.6M | ||
| +0.47% | -3.19% | +2.82% | +49.33% | 76.84B | ||
| +0.41% | -2.11% | -11.02% | +17.33% | 39.12B | ||
| +0.99% | -6.81% | -22.94% | -33.87% | 32.05B | ||
| +0.73% | -0.97% | +19.73% | +30.07% | 26B | ||
| -1.21% | +0.67% | +87.09% | -7.79% | 21.16B | ||
| +4.24% | +2.22% | +14.71% | +5.78% | 19.85B | ||
| -0.08% | -3.74% | -41.03% | -36.16% | 18.2B | ||
| -1.85% | -7.02% | +69.72% | -47.45% | 15.15B | ||
| +0.07% | -3.02% | -2.64% | -5.18% | 13.94B | ||
| Average | +0.72% | -2.50% | +10.22% | -7.37% | 26.23B | |
| Weighted average by Cap. | +0.70% | -2.89% | +7.51% | +10.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9.94M 13.31M 11.66M 10.76M 18.85M 1.27B 19.15M 129M 50.42M 626M 49.95M 48.9M 2.15B | 11.56M 15.49M 13.57M 12.52M 21.92M 1.48B 22.28M 150M 58.65M 728M 58.1M 56.88M 2.5B |
| Net income | - | - |
| Net Debt | -2.45M -3.28M -2.87M -2.65M -4.64M -313M -4.72M -31.7M -12.43M -154M -12.31M -12.05M -531M | -2.02M -2.71M -2.37M -2.19M -3.84M -258M -3.9M -26.18M -10.26M -127M -10.17M -9.95M -438M |
Employees
28
Sector
Specialty Chemicals
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | GBX 108.50 | 0.00% | 16,532 |
| 09/07/26 | GBX 108.50 | +0.46% | 5,351 |
| 08/07/26 | GBX 108.00 | -0.46% | 22,206 |
| 07/07/26 | GBX 108.50 | -2.25% | 25,243 |
| 06/07/26 | GBX 111.00 | +1.37% | 8,999 |
Sell
Buy

Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.085GBP
Average target price
3.250GBP
Spread / Average Target
+199.54%
Net sales - Rate of surprise
- Stock Market
- Stocks
- REVO Stock
Select your edition
All financial news and data tailored to specific country editions

















